Cara Therapeutics, Inc. (CARA)
Pre-market:
| Previous close | 5.0450 |
| Open | 5.0400 |
| Bid | 4.0800 x 1200 |
| Ask | 5.4800 x 800 |
| Day's range | 4.9100 - 5.1200 |
| 52-week range | 4.8500 - 13.9650 |
| Volume | |
| Avg. volume | 599,068 |
| Market cap | 265.444M |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | 27.91 |
| EPS (TTM) | 0.1770 |
| Earnings date | 08 May 2023 - 12 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 23.75 |
- Simply Wall St.
Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade
The analysts covering Cara Therapeutics, Inc. ( NASDAQ:CARA ) delivered a dose of negativity to shareholders today, by...
- Yahoo Finance Video
Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss
Yahoo Finance Live anchors Julie Hyman and Jared Blikre discuss fourth-quarter earnings for Cara Therapeutics.
- Motley Fool
These 2 Stocks Are Plunging After Hours Monday
The stock market was mixed to start the week on Monday, as investors seemed more comfortable waiting to find out what Federal Reserve chair Jerome Powell will say later in the week about the state of the U.S. economy and the central bank's approach to interest rates. The Dow Jones Industrial Average (DJINDICES: ^DJI) and S&P 500 (SNPINDEX: ^GSPC) managed to gain ground on the day, but the Nasdaq Composite (NASDAQINDEX: ^IXIC) fell back slightly. Calavo Growers (NASDAQ: CVGW) is well known for its avocado production, and its quarterly financial results weren't good enough to keep investors satisfied.
